Literature DB >> 27856471

Role of the intestinal mucosa in acute gastrointestinal GVHD.

Jonathan U Peled1,2, Alan M Hanash1, Robert R Jenq1,2.   

Abstract

Intestinal graft-versus-host disease (GVHD) remains a significant obstacle to the success of allogeneic hematopoietic cell transplantation. The intestinal mucosa comprises the inner lining of the intestinal tract and maintains close proximity with commensal microbes that reside within the intestinal lumen. Recent advances have significantly improved our understanding of the interactions between the intestinal mucosa and the enteric microbiota. Changes in host mucosal tissue and commensals posttransplant have been actively investigated, and provocative insights into mucosal immunity and the enteric microbiota are now being translated into clinical trials of novel approaches for preventing and treating acute GVHD. In this review, we summarize recent findings related to aspects of the intestinal mucosa during acute GVHD.
© 2016 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh：

Year:  2016        PMID： 27856471      PMCID： PMC5114486          DOI： 10.1182/blood-2016-06-716738

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  125 in total

1.  Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

Authors:  J Marius Munneke; Andreas T Björklund; Jenny M Mjösberg; Karin Garming-Legert; Jochem H Bernink; Bianca Blom; Cynthia Huisman; Marinus H J van Oers; Hergen Spits; Karl-Johan Malmberg; Mette D Hazenberg
Journal:  Blood       Date:  2014-05-22       Impact factor: 22.113

Review 2.  The mycobiota: interactions between commensal fungi and the host immune system.

Authors:  David M Underhill; Iliyan D Iliev
Journal:  Nat Rev Immunol       Date:  2014-06       Impact factor: 53.106

3.  Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.

Authors:  Robert R Jenq; Ying Taur; Sean M Devlin; Doris M Ponce; Jenna D Goldberg; Katya F Ahr; Eric R Littmann; Lilan Ling; Asia C Gobourne; Liza C Miller; Melissa D Docampo; Jonathan U Peled; Nicholas Arpaia; Justin R Cross; Tatanisha K Peets; Melissa A Lumish; Yusuke Shono; Jarrod A Dudakov; Hendrik Poeck; Alan M Hanash; Juliet N Barker; Miguel-Angel Perales; Sergio A Giralt; Eric G Pamer; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-11       Impact factor: 5.742

4.  Proteobacteria-specific IgA regulates maturation of the intestinal microbiota.

Authors:  Julie Mirpuri; Megan Raetz; Carolyn R Sturge; Cara L Wilhelm; Alicia Benson; Rashmin C Savani; Lora V Hooper; Felix Yarovinsky
Journal:  Gut Microbes       Date:  2013-09-25

5.  α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice.

Authors:  Hidetaka Uryu; Daigo Hashimoto; Koji Kato; Eiko Hayase; Satomi Matsuoka; Reiki Ogasawara; Shuichiro Takahashi; Yoshinobu Maeda; Hiromi Iwasaki; Toshihiro Miyamoto; Shinobu Saijo; Yoichiro Iwakura; Geoffrey R Hill; Koichi Akashi; Takanori Teshima
Journal:  Blood       Date:  2015-03-04       Impact factor: 22.113

6.  Cesarean section and chronic immune disorders.

Authors:  Astrid Sevelsted; Jakob Stokholm; Klaus Bønnelykke; Hans Bisgaard
Journal:  Pediatrics       Date:  2014-12-01       Impact factor: 7.124

7.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.

Authors:  Maria G Dominguez-Bello; Elizabeth K Costello; Monica Contreras; Magda Magris; Glida Hidalgo; Noah Fierer; Rob Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 8.  Graft-versus-host disease.

Authors:  Warren D Shlomchik
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

9.  Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome.

Authors:  Daniela Weber; Peter J Oefner; Andreas Hiergeist; Josef Koestler; André Gessner; Markus Weber; Joachim Hahn; Daniel Wolff; Frank Stämmler; Rainer Spang; Wolfgang Herr; Katja Dettmer; Ernst Holler
Journal:  Blood       Date:  2015-07-24       Impact factor: 22.113

10.  Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cells.

Authors:  Vanessa M Hubbard-Lucey; Yusuke Shono; Katie Maurer; Mallory L West; Natalie V Singer; Carly G K Ziegler; Cecilia Lezcano; Ana Carolina Fragoso Motta; Karin Schmid; Samuel M Levi; George F Murphy; Chen Liu; Jeffrey D Winkler; Ravi K Amaravadi; Gerhard Rogler; Anne M Dickinson; Ernst Holler; Marcel R M van den Brink; Ken Cadwell
Journal:  Immunity       Date:  2014-10-09       Impact factor: 31.745
View more
  20 in total

Review 1.  Microbiome-intestine cross talk during acute graft-versus-host disease.

Authors:  Hind Rafei; Robert R Jenq
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 2.  Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.

Authors:  Steven Naymagon; Leonard Naymagon; Serre-Yu Wong; Huaibin Mabel Ko; Anne Renteria; John Levine; Jean-Frederic Colombel; James Ferrara
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-27       Impact factor: 46.802

3.  Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.

Authors:  George B McDonald; Laura Tabellini; Barry E Storer; Paul J Martin; Richard L Lawler; Steven L Rosinski; H Gary Schoch; John A Hansen
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-03       Impact factor: 5.742

4.  Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.

Authors:  Zachariah DeFilipp; Jonathan U Peled; Shuli Li; Jasmin Mahabamunuge; Zeina Dagher; Ann E Slingerland; Candice Del Rio; Betsy Valles; Maria E Kempner; Melissa Smith; Jami Brown; Bimalangshu R Dey; Areej El-Jawahri; Steven L McAfee; Thomas R Spitzer; Karen K Ballen; Anthony D Sung; Tara E Dalton; Julia A Messina; Katja Dettmer; Gerhard Liebisch; Peter Oefner; Ying Taur; Eric G Pamer; Ernst Holler; Michael K Mansour; Marcel R M van den Brink; Elizabeth Hohmann; Robert R Jenq; Yi-Bin Chen
Journal:  Blood Adv       Date:  2018-04-10

Review 5.  Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.

Authors:  Yusuke Shono; Marcel R M van den Brink
Journal:  Nat Rev Cancer       Date:  2018-02-16       Impact factor: 60.716

Review 6.  Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.

Authors:  James Lm Ferrara; Christopher M Smith; Julia Sheets; Pavan Reddy; Jonathan S Serody
Journal:  J Clin Invest       Date:  2017-06-05       Impact factor: 14.808

Review 7.  New therapeutic targets and biomarkers for acute graft-versus-host disease (GVHD).

Authors:  Hannah Choe; James L M Ferrara
Journal:  Expert Opin Ther Targets       Date:  2021-11-01       Impact factor: 6.902

Review 8.  Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?

Authors:  Lucy E Horton; Nina M Haste; Randy A Taplitz
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

Review 9.  The microbiome in pediatric oncology.

Authors:  Seth J Rotz; Christopher E Dandoy
Journal:  Cancer       Date:  2020-06-13       Impact factor: 6.860

10.  Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study.

Authors:  Niloufer Khan; Sarah Lindner; Antonio L C Gomes; Sean M Devlin; Gunjan L Shah; Anthony D Sung; Craig S Sauter; Heather J Landau; Parastoo B Dahi; Miguel-Angel Perales; David J Chung; Alexander M Lesokhin; Anqi Dai; Annelie Clurman; John B Slingerland; Ann E Slingerland; Daniel G Brereton; Paul A Giardina; Molly Maloy; Gabriel K Armijo; Carlos Rondon-Clavo; Emily Fontana; Lauren Bohannon; Sendhilnathan Ramalingam; Amy T Bush; Meagan V Lew; Julia A Messina; Eric Littmann; Ying Taur; Robert R Jenq; Nelson J Chao; Sergio Giralt; Kate A Markey; Eric G Pamer; Marcel R M van den Brink; Jonathan U Peled
Journal:  Blood       Date:  2021-03-18       Impact factor: 25.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.